Appendix 1. Survey data
We analysed data from the nationally-representative Service Provision Assessment (SPA) surveys within the last 10 years (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) conducted by the Demographic and Health Surveys (DHS) program. We included all 10 countries that had SPA microdata publicly available within this reference period (Bangladesh, Haiti, Kenya, Malawi, Namibia, Nepal, Rwanda, Senegal, Tanzania and Uganda).
1-10
The SPA are cross-sectional surveys of health facilities, staff and clients that collect information on the overall availability and delivery of a range of services in a country. The sample of health facilities is usually selected to provide indicators representative at the national level for the different facility types and health facility managing authority (public and non-public) as well as aggregate indicators at the regional level. We obtained permission to use these datasets for these analyses from the DHS program, which obtained informed consent from all survey participants and authorization from governments to conduct the data collection and distribute the data for research purposes.
All health facilities with completed interviews that reported offering delivery services were included in the analysis (reports were by the person in charge of the facility or the most knowledgeable person about services). Appendix table 1 shows for each country survey and by facility level the number of facilities surveyed, the number and percentage with a complete survey, and the number and percentage that provide delivery services.
Appendix 2. Classification of health facilities
Appendix Table 2 shows which types of facilities were classified into primary-level and referral-level categories in each country.
Appendix 3. Abortion-related contextual indicators for 10 countries
To describe each country context, we conducted a desk-based review of available literature on selected indicators related to postabortion need and services, including: the proportion of lower and higher level facilities that conduct deliveries, legal conditions for induced abortion, the rate of induced abortion, treatment rate of abortion-related complications, maternal mortality ratios, the availability of misoprostol, and policies on postabortion care.
Eight of the 10 countries included in the analysis (Haiti, Kenya, Malawi, Namibia, Rwanda, Senegal, Tanzania and Uganda) legally restrict induced abortion to a limited number of conditions, which compels women to seek clandestine and often unsafe terminations of pregnancy (Appendix Table 3 ). The legal conditions for induced abortion have been expanded in Kenya and Rwanda since the SPA surveys used in this study were conducted, but the legal conditions still remain restrictive. In Bangladesh, menstrual regulation is available on request when a woman's period is delayed (up to 10 weeks since the last period). In Nepal, induced abortion is permissible on request up to 12 weeks' gestation. The most recent abortion rate varies from 16 to 48 induced abortions per 1,000 women of reproductive age, and annual treatment rates for abortion complications range from 6 to 14 cases per 1,000 women ages 15 to 44.
In most countries the provision of PAC is allowed at both primary and referral-level facilities (this information was not specified in the WHO global policies database for Kenya, Malawi, Rwanda or Tanzania). Postabortion counselling for contraceptive methods is intended to be part of PAC in eight of the ten countries (it is not specified in Namibia's policy and there are no data for Tanzania). In the year the SPA surveys were conducted, misoprostol was not included in the national list of essential medicines or other authorized drug lists for gynaecological indications in Kenya, Namibia, Rwanda, It is now included in Kenya and Uganda, and is recognized as useful for management of abortion in Namibia treatment guidelines, although it is not on the essential medicine list. [16] [17] [18] Appendix Table 3 presents national data on selected, abortion-related contextual indicators.
Appendix 4. Signal functions data for 10 countries
Appendix Table 4 shows all estimates for each signal function in basic and comprehensive PAC and the composite indicators, for primary-level, referral-level and all facilities in each country.
The question wording in the SPA surveys has changed over time such that our analysis includes data based on slightly different questions. For example, removal of retained products was assessed by one of two questions:
• "Please tell me if any of the following interventions have ever been carried out by providers as part of their work in this facility, and if so, whether the intervention has been carried out at least once during the past 3 months: Removal of retained products of conception" or • "Has manual vacuum aspiration or D & C been used to remove retained products of conception by this facility during the past 3 months?"
We verified whether the facilities had the basic equipment or commodities needed to deliver the services for three signal functions. For removal of retained products, we examined availability in the health facility of a surgical apparatus or misoprostol; for parenteral uterotonics, we examined availability of injectable oxytocin, ergometrine or other uterotonics; for provision of blood transfusions, we examined availability of blood typing services. We present these additional data but do not use the proportions of capable facilities with required equipment or drugs, but rather present the overall proportion of health facilities with the aggregated signal functions at the basic or comprehensive PAC levels. From a list of 4,719 facilities, 1,000 facilities were selected (8 of which were duplicates, resulting in a final sample of 992 facilities). All nonspecialized government hospitals, hospitals with 100 or more in-patient beds, and primary health centers were included in the sample. The sample was designed to provide representative results at the national and regional levels, as well as for different facility types and managing authorities. From a list of 3,000 health facilities, a sample of 500 facilities was selected (9 of which could not to be surveyed or replaced, resulting in a final sample size of 491). The sample included all hospitals and approximately half of health center (HC) IVs. The sample of lower-level health facilities (HC-III and HC-II) was designed to provide representative results at the national and regional levels. Two facilities originally sampled as HC-IIs were found in the field to be actually HC-IVs.
Rwanda
* Completed interviews are those where the facility has completed all four components of the SPA survey: a facility inventory questionnaire, client-provider observation protocols, client exit questionnaires and health worker questionnaires. n/a n/a n/a n/a n/a n/a 69% 78% 72% n/a n/a n/a Availability of D&C kit n/a n/a n/a n/a n/a n/a 16% 59% 33% n/a n/a n/a Availability of misoprostol 45% 67% 56% 9% 28% 12% n/a n/a n/a 10% 47% 16% n/a n/a n/a 60% 97% 82% Availability of misoprostol n/a n/a n/a 43% 74% 48% n/a n/a n/a 
